4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001567619-22-004543
10% owner bought 17,500 shares at an average $4.45 ($77,900)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc 10% owner | 2022-02-10 | Purchase | +5,000 | $4.58 | $22,900 | 5,163,286 | D: show line 1 in the form |
| Cambrian BioPharma Inc 10% owner | 2022-02-11 | Purchase | +12,500 | $4.40 | $55,000 | 5,175,786 | D: show line 2 in the form |
| Open-market purchases · 17,500 sh · avg $4.45 · $77,900 | |||||||
Loading xslF345X03/doc1.xml…